Fundraising FoxIstari Oncology
Morrisville, US · Delaware corporation · 1 known investors
Find your way into Istari Oncology
276 people in our graph share verified history with the Istari Oncology team — schools, employers, funds. One of them is your warm intro.
Ryan Stewartunlockedknows Marc Banjak · together at Dova Pharmaceuticals (overlapped)
×3knows the team · via PRA Health Sciences
×4knows the team · via PPD
×4knows the team · via United States Air Force
Founders & leadership
MB
Marc BanjakGeneral Counsel and Corporate Secretary2021–2021Marc Banjak is an executive officer at Istari Oncology with extensive experience in legal operations for medical device and pharmaceutical companies, including contract negotiation and regulatory compliance.
WG
William G. NicholsExecutive
MR
Matthew R. StoberExecutive
Board
RB
Robert BonczekBoard director
RC
Raymond CheongBoard director
VS
Victor SandorBoard director
SN
Sean NolanBoard director
DP
Dani P. BolognesiBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$48.6M disclosed across 3 rounds · 2017–2021
▶$43.5MraisedApr 2021 · 17 investors · BiotechnologyRule 506(b)
▶$43.5MraisedApr 2021 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert BonczekDirector
- Raymond CheongDirector
- Marc BanjakExecutive Officer
- Matthew W. FarberExecutive Officer
- William G. NicholsExecutive Officer
- Victor SandorDirector
- Sean NolanDirector
- Matthew R. StoberExecutive Officer, Director
- Dani P. BolognesiDirector
- Offering amount
- $70M
- Amount sold
- $43.5M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedMay 2017 · 10 investors · BiotechnologyRule 506(b)
▶$1.1MraisedMay 2017 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert BonczekExecutive Officer, Director
- Dani P. BolognesiExecutive Officer, Director
- Henry FriedmanExecutive Officer
- Timothy J. CreechExecutive Officer
- Darell D. BignerDirector, Promoter
- Offering amount
- $4M
- Amount sold
- $1.1M
- First sale
- May 2017
- Incorporated
- Corporation, North Carolina, 2014
- Federal exemptions
- 06b
▶$4MraisedFeb 2017 · 1 investors · Other Health CareRule 506(b)
▶$4MraisedFeb 2017 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Darell D. BignerExecutive Officer, Director, Promoter
- Timothy J. CreechExecutive Officer
- Dani P. BolognesiExecutive Officer, Director
- Henry FriedmanExecutive Officer
- Robert BonczekExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Jan 2017
- Incorporated
- Corporation, North Carolina, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Istari Oncology's investors?
- Istari Oncology's investors include Pappas Capital.
- How much funding has Istari Oncology raised?
- Istari Oncology has disclosed $48.6M raised across 3 rounds.
- Where is Istari Oncology headquartered?
- Istari Oncology is headquartered in Morrisville, US.